查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2035256

醫療設備市場預測至2034年－按產品類型、器材分類、應用、最終用戶、通路和地區分類的全球分析

Medical Devices Market Forecasts to 2034 - Global Analysis By Product Type, Device Class, Application, End User, Distribution Channel, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球醫療設備市場規模將達到 6,090 億美元，並在預測期內以 6.2% 的複合年成長率成長，到 2034 年將達到 9,854 億美元。

醫療設備是指在各種醫療環境中用於診斷、監測、預防和治療疾病的各種儀器、設備和技術。該市場涵蓋了從簡單的繃帶和體溫計到複雜的成像系統、手術機器人和植入式心臟心律調節器等各種產品。慢性病盛行率的上升、全球人口老化以及持續的技術創新正在改變世界各地的醫療服務體系。隨著醫療系統日益重視早期診斷、微創治療和居家照護，各地區對先進醫療設備的需求持續成長。

慢性病和文明病的盛行率不斷上升

全球慢性疾病負擔日益加重，例如糖尿病、心血管疾病、呼吸系統疾病和癌症，這直接推動了對診斷和治療醫療設備的需求。隨著人口老化，這一趨勢進一步加劇，因為老年人需要更頻繁的監測、手術介入和長期疾病管理方案。醫療機構持續投資於能夠改善患者預後並控制成本的技術，因此，持續血糖監測儀、心臟支架、人工呼吸器和影像系統等醫療器材的需求持續成長。目前尚無跡象顯示這種人口結構變化會逆轉，預計在預測期內，各類醫療設備的需求將保持穩定。

嚴格的監管核准流程和合規成本

製造商必須經歷漫長而昂貴的流程才能將新的醫療設備推向市場。 FDA 和 EMA 等監管機構要求提供大量的臨床證據，以證明其安全性和有效性。上市前核准流程可能長達數年，不僅會延遲獲利，還會增加研發成本，最終導致醫療設備價格上漲。上市後監管要求、品管系統認證和定期監管審計也構成持續的營運負擔。中小企業尤其難以滿足這些要求，這可能會限制其創新和市場准入。雖然這些監管障礙對於保障病患安全至關重要，但它們也構成了市場成長和整合的重大阻礙。

遠端醫療和遠端患者監護的擴展

遠端醫療服務的快速普及為支援遠距患者管理的互聯醫療設備帶來了巨大的機會。穿戴式感測器、智慧吸入器、遠距心電圖監測儀和數位聽診器等設備使醫療專業人員能夠持續追蹤患者的健康狀況，而無需患者前往醫院。這種轉變將緩解醫療機構的擁擠狀況，降低醫療服務成本，並改善農村地區和行動不便者的就醫途徑。主要市場的報銷政策正在擴大遠端監測服務的覆蓋範圍，凸顯了這些設備的效用。隨著5G網路的擴展和資料互通性標準的改進，醫療設備與虛擬醫療平台的整合將加速，為創新製造商開闢新的收入來源。

網路安全漏洞與資料隱私風險

隨著醫療設備與醫院網路和網路的連結日益緊密，惡意攻擊者的攻擊面也不斷擴大。輸液幫浦、心臟節律器、影像系統和患者監護儀等設備都已被發現有安全漏洞，這些漏洞可能威脅病人安全或導致高度敏感的健康資訊外洩。針對醫療系統的高調勒索軟體攻擊事件加劇了監管機構的審查力度，而新的網路安全要求也增加了研發的複雜性和成本。大規模安全漏洞一旦影響廣泛部署的醫療設備，就會迅速削弱病人的信任，引發損害賠償訴訟，改變整個產業的競爭格局，並帶來前所未有的合規負擔。

新型冠狀病毒（COVID-19）的影響：

新冠疫情徹底改變了醫療設備市場，對人工呼吸器、氧氣濃縮機、診斷檢測套組和個人防護工具（PPE）的需求空前高漲，同時也對部分外科器材市場造成了衝擊。供應鏈面臨巨大壓力，迫使製造商實現貨源多元化並增加庫存儲備。隨著醫療機構盡可能減少面對面接觸，遠距遠端醫療設備的普及應用也隨之加速。疫情也促使監管部門採取更靈活的措施，例如發布緊急使用授權（EUA）並暫時縮短核准流程。長期影響包括：更重視疫情防範、醫療服務模式去中心化，以及全球醫療系統持續加強對感染控制和呼吸支持設備的投入。

在預測期內，醫院領域預計將佔據最大的市場佔有率。

在預測期內，醫院預計將佔據最大的市場佔有率。醫院作為複雜診斷程序、外科手術和重症監護的中心，發揮關鍵作用。醫院擁有種類繁多的醫療設備，從基本的病患監測設備到先進的影像系統，例如磁振造影（MRI）和電腦斷層掃描（CT）掃描儀。由於醫院集中了專業的醫務人員、手術室和急診科，因此對大型設備、耗材和植入式醫療設備的需求穩定。大規模的採購能力和成熟的採購關係進一步鞏固了醫院的市場主導地位，醫院的醫療器材支出佔全球醫療設備支出的近一半。

在預測期內，線上通路細分市場預計將呈現最高的複合年成長率。

在預測期內，線上通路預計將呈現最高的成長率，徹底改變醫療設備在專業市場和消費市場觸達終端用戶的方式。電子商務平台將使患者能夠方便地直接購買家用設備，例如血壓計、血糖試紙、持續性呼吸道正壓通氣（CPAP）呼吸器和助行器。對於醫療機構而言，專業的B2B線上入口網站簡化了採購流程，提供具有競爭力的價格、自動化的庫存管理和快速的配送選項。疫情加速了數位化採購管道的普及，而物流、支付安全和產品認證的持續改進也持續推動著這一趨勢，使線上分銷成為最快捷的市場管道。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其先進的醫療基礎設施、高人均醫療支出以及先進醫療技術的快速普及。作為最大的國內市場，美國擁有強大的醫療設備創新生態系統、有利的報銷環境和充足的研發資金。主要的醫療設備製造商總部都設在該地區，確保了與臨床需求的緊密合作。嬰兒潮世代的老化和高肥胖率正在推動對慢性病管理設備的需求。諸如FDA突破性醫療器材計畫等監管途徑正在加速創新產品的普及，並在整個預測期內鞏固北美的領先地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於新興經濟體醫療基礎設施的現代化、保險覆蓋範圍的擴大以及醫療旅遊的興起。在中國和印度，醫院建設正在加速，診斷檢查室不斷增加，需要尖端醫療設備的手術數量也在增加。政府致力於促進國內醫療設備製造業的發展，這在擴大醫療服務覆蓋範圍的同時，也降低了對進口的依賴。不斷成長的中產階級推動了對更高品質醫療保健的需求，促進了先進影像設備、微創手術器材和居家醫療設備的普及。國際製造商正在建立區域生產基地和培訓中心，而當地企業也不斷獲得監管部門的核准，所有這些因素共同加速了全部區域的市場擴張。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球醫療設備市場：依產品類型分類

  • 診斷設備
    • 體外診斷醫療設備（IVD）
    • 醫療影像設備
  • 用於治療的醫療設備
    • 心血管設備
    • 整形外科器械
    • 呼吸醫療設備
    • 糖尿病護理設備
  • 外科醫療設備
    • 微創外科醫療設備
    • 一般外科器械
  • 病患監測設備
  • 藥物輸送裝置
  • 維生設備
  • 輔助及復健設備

第6章 全球醫療設備市場：依器材分類

  • 一級
  • 二類
  • 三級

第7章 全球醫療設備市場：依應用領域分類

  • 循環系統
  • 整形外科
  • 神經病學
  • 腫瘤學
  • 呼吸護理
  • 糖尿病護理
  • 眼科
  • 婦科和泌尿系統
  • 一般外科
  • 其他用途

第8章 全球醫療設備市場：依最終用戶分類

  • 醫院
  • 門診手術中心
  • 診所
  • 診斷檢查室
  • 居家醫療環境
  • 其他最終用戶

第9章 全球醫療設備市場：依分銷管道分類

  • 直銷
  • 銷售代理
  • 線上管道

第10章：全球醫療設備市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章：公司簡介

  • Medtronic plc
  • Johnson & Johnson
  • Siemens Healthineers AG
  • GE HealthCare Technologies Inc.
  • Philips NV
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Stryker Corporation
  • Becton Dickinson and Company
  • Danaher Corporation
  • Zimmer Biomet Holdings Inc.
  • Smith & Nephew plc
  • Fresenius Medical Care AG & Co. KGaA
  • Canon Medical Systems Corporation
  • Olympus Corporation
  • Terumo Corporation
Product Code: SMRC35684

According to Stratistics MRC, the Global Medical Devices Market is accounted for $609.0 billion in 2026 and is expected to reach $985.4 billion by 2034 growing at a CAGR of 6.2% during the forecast period. Medical devices encompass a vast range of instruments, apparatuses, and technologies used for diagnosing, monitoring, preventing, and treating medical conditions across healthcare settings. This market includes everything from simple bandages and thermometers to complex imaging systems, surgical robots, and implantable pacemakers. The increasing prevalence of chronic diseases, aging global populations, and continuous technological innovation are reshaping healthcare delivery worldwide. As healthcare systems emphasize early diagnosis, minimally invasive procedures, and home-based care, the demand for advanced medical devices continues to expand across all regions.

Market Dynamics:

Driver:

Rising prevalence of chronic and lifestyle-related diseases

The global burden of chronic conditions such as diabetes, cardiovascular disease, respiratory disorders, and cancer is escalating, directly fueling demand for diagnostic and therapeutic medical devices. An aging population further compounds this trend, as older adults require more frequent monitoring, surgical interventions, and long-term disease management solutions. Continuous glucose monitors, cardiac stents, ventilators, and imaging systems are experiencing sustained growth as healthcare providers invest in technologies that improve patient outcomes while managing costs. This demographic shift shows no signs of reversing, ensuring consistent demand across multiple device categories throughout the forecast period.

Restraint:

Stringent regulatory approval processes and compliance costs

Manufacturers face lengthy and expensive pathways to bring new medical devices to market, with regulatory bodies like the FDA and EMA requiring extensive clinical evidence for safety and efficacy. Premarket approval timelines can extend several years, delaying revenue generation and increasing development costs that ultimately raise device prices. Post-market surveillance requirements, quality management system certifications, and periodic regulatory audits add ongoing operational burdens. Smaller companies particularly struggle with these requirements, potentially limiting innovation and market entry. These regulatory hurdles, while essential for patient safety, create significant barriers that restrain market growth and consolidation.

Opportunity:

Telemedicine and remote patient monitoring expansion

The rapid adoption of telehealth services has created substantial opportunities for connected medical devices that enable remote patient management. Wearable sensors, smart inhalers, remote cardiac monitors, and digital stethoscopes allow healthcare providers to track patient health continuously without hospital visits. This shift reduces facility congestion, lowers healthcare delivery costs, and improves access for rural or mobility-limited populations. Reimbursement policies in major markets are increasingly covering remote monitoring services, validating device utility. As 5G networks expand and data interoperability standards improve, the integration of medical devices into virtual care platforms will accelerate, opening new revenue streams for innovative manufacturers.

Threat:

Cybersecurity vulnerabilities and data privacy risks

As medical devices become increasingly connected to hospital networks and the internet, they present expanding attack surfaces for malicious actors. Infusion pumps, pacemakers, imaging systems, and patient monitors have all demonstrated potential security weaknesses that could compromise patient safety or expose sensitive health information. High-profile ransomware attacks on healthcare systems have heightened regulatory scrutiny, with new cybersecurity requirements adding development complexity and costs. A major security breach affecting widely deployed devices could rapidly erode patient trust and trigger liability claims, potentially reshaping the competitive landscape and imposing unprecedented compliance burdens across the industry.

Covid-19 Impact:

The COVID-19 pandemic dramatically reshaped medical device markets, creating unprecedented demand for ventilators, oxygen concentrators, diagnostic test kits, and personal protective equipment while disrupting elective procedure device markets. Supply chains experienced severe strain, prompting manufacturers to diversify sourcing and increase inventory buffers. Telehealth-compatible devices saw accelerated adoption as healthcare systems minimized in-person contact. The pandemic also spurred regulatory flexibilities, including emergency use authorizations, which temporarily shortened approval timelines. Long-term effects include heightened focus on pandemic preparedness, decentralized healthcare delivery models, and sustained investment in infection control and respiratory support devices across global healthcare systems.

The Hospitals segment is expected to be the largest during the forecast period

The Hospitals segment is expected to account for the largest market share during the forecast period, serving as the primary hub for complex diagnostic procedures, surgical interventions, and intensive patient care. Hospitals maintain extensive inventories of medical devices ranging from basic patient monitoring equipment to advanced imaging systems such as MRI and CT scanners. The concentration of specialized medical professionals, surgical suites, and emergency departments within hospital settings ensures consistent demand for capital equipment, consumables, and implantable devices. Large-scale purchasing power and established procurement relationships further consolidate this segment's dominance, with hospitals accounting for nearly half of all medical devices spending globally.

The Online Channels segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Online Channels segment is predicted to witness the highest growth rate, revolutionizing how medical devices reach end users across both professional and consumer markets. E-commerce platforms enable convenient purchasing of home-use devices such as blood pressure monitors, glucose test strips, continuous positive airway pressure machines, and mobility aids directly to patients. For healthcare facilities, specialized B2B online portals streamline procurement, offering competitive pricing, automated inventory management, and rapid delivery options. The pandemic accelerated acceptance of digital purchasing channels and ongoing improvements in logistics, payment security, and product authentication continue to drive adoption, making online distribution the fastest-growing route to market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, underpinned by sophisticated healthcare infrastructure, high per capita healthcare spending, and rapid adoption of advanced medical technologies. The United States, as the largest national market, benefits from a strong medical device innovation ecosystem, favorable reimbursement landscape, and substantial research funding. Leading device manufacturers are headquartered in the region, ensuring close alignment with clinical needs. Aging baby boomer demographics and high obesity rates drive chronic disease management device demand. Regulatory pathways like the FDA's breakthrough device program accelerate innovation access, cementing North America's leadership throughout the forecast period.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by healthcare infrastructure modernization, expanding insurance coverage, and rising medical tourism across emerging economies. China and India are witnessing rapid hospital construction, diagnostic laboratory proliferation, and increasing surgical procedure volumes requiring modern medical equipment. Government initiatives promoting domestic medical device manufacturing reduce import dependence while expanding access. Growing middle-class populations demand higher-quality healthcare, driving adoption of advanced imaging, minimally invasive surgical tools, and homecare devices. International manufacturers are establishing regional production and training centers, while local companies gain regulatory approvals, collectively accelerating market expansion throughout Asia Pacific.

Key players in the market

Some of the key players in Medical Devices Market include Medtronic plc, Johnson & Johnson, Siemens Healthineers AG, GE HealthCare Technologies Inc., Philips N.V., Abbott Laboratories, Boston Scientific Corporation, Stryker Corporation, Becton Dickinson and Company, Danaher Corporation, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Fresenius Medical Care AG & Co. KGaA, Canon Medical Systems Corporation, Olympus Corporation, and Terumo Corporation.

Key Developments:

In April 2026, Medtronic expanded its digital surgery ecosystem through a new integration between the Medtronic Stealth AXiS(TM) surgical navigation system and GE HealthCare's bkActiv(TM) intraoperative ultrasound.

In April 2026, J&J MedTech showcased 12-month interim results for the VARIPULSE(R) Pulsed Field Ablation (PFA) platform at EHRA 2026, demonstrating high safety and effectiveness in treating atrial fibrillation.

In March 2026, GE HealthCare completed the acquisition of Intelerad, accelerating its shift toward cloud-first enterprise imaging and AI-driven precision care.

Product Types Covered:

  • Diagnostic Devices
  • Therapeutic Devices
  • Surgical Devices
  • Patient Monitoring Devices
  • Drug Delivery Devices
  • Life Support Equipment
  • Assistive and Rehabilitation Devices

Device Classes Covered:

  • Class I
  • Class II
  • Class III

Applications Covered:

  • Cardiology
  • Orthopedics
  • Neurology
  • Oncology
  • Respiratory Care
  • Diabetes Care
  • Ophthalmology
  • Gynecology and Urology
  • General Surgery
  • Other Applications

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Diagnostic Laboratories
  • Homecare Settings
  • Other End Users

Distribution Channels Covered:

  • Direct Sales
  • Distributors
  • Online Channels

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Medical Devices Market, By Product Type

  • 5.1 Diagnostic Devices
    • 5.1.1 In-vitro Diagnostic (IVD) Devices
    • 5.1.2 Diagnostic Imaging Devices
  • 5.2 Therapeutic Devices
    • 5.2.1 Cardiovascular Devices
    • 5.2.2 Orthopedic Devices
    • 5.2.3 Respiratory Devices
    • 5.2.4 Diabetes Care Devices
  • 5.3 Surgical Devices
    • 5.3.1 Minimally Invasive Surgical Devices
    • 5.3.2 General Surgical Instruments
  • 5.4 Patient Monitoring Devices
  • 5.5 Drug Delivery Devices
  • 5.6 Life Support Equipment
  • 5.7 Assistive and Rehabilitation Devices

6 Global Medical Devices Market, By Device Class

  • 6.1 Class I
  • 6.2 Class II
  • 6.3 Class III

7 Global Medical Devices Market, By Application

  • 7.1 Cardiology
  • 7.2 Orthopedics
  • 7.3 Neurology
  • 7.4 Oncology
  • 7.5 Respiratory Care
  • 7.6 Diabetes Care
  • 7.7 Ophthalmology
  • 7.8 Gynecology and Urology
  • 7.9 General Surgery
  • 7.10 Other Applications

8 Global Medical Devices Market, By End User

  • 8.1 Hospitals
  • 8.2 Ambulatory Surgical Centers
  • 8.3 Clinics
  • 8.4 Diagnostic Laboratories
  • 8.5 Homecare Settings
  • 8.6 Other End Users

9 Global Medical Devices Market, By Distribution Channel

  • 9.1 Direct Sales
  • 9.2 Distributors
  • 9.3 Online Channels

10 Global Medical Devices Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 Medtronic plc
  • 13.2 Johnson & Johnson
  • 13.3 Siemens Healthineers AG
  • 13.4 GE HealthCare Technologies Inc.
  • 13.5 Philips N.V.
  • 13.6 Abbott Laboratories
  • 13.7 Boston Scientific Corporation
  • 13.8 Stryker Corporation
  • 13.9 Becton Dickinson and Company
  • 13.10 Danaher Corporation
  • 13.11 Zimmer Biomet Holdings Inc.
  • 13.12 Smith & Nephew plc
  • 13.13 Fresenius Medical Care AG & Co. KGaA
  • 13.14 Canon Medical Systems Corporation
  • 13.15 Olympus Corporation
  • 13.16 Terumo Corporation

List of Tables

  • Table 1 Global Medical Devices Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Medical Devices Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Medical Devices Market Outlook, By Diagnostic Devices (2023-2034) ($MN)
  • Table 4 Global Medical Devices Market Outlook, By In-vitro Diagnostic (IVD) Devices (2023-2034) ($MN)
  • Table 5 Global Medical Devices Market Outlook, By Diagnostic Imaging Devices (2023-2034) ($MN)
  • Table 6 Global Medical Devices Market Outlook, By Therapeutic Devices (2023-2034) ($MN)
  • Table 7 Global Medical Devices Market Outlook, By Cardiovascular Devices (2023-2034) ($MN)
  • Table 8 Global Medical Devices Market Outlook, By Orthopedic Devices (2023-2034) ($MN)
  • Table 9 Global Medical Devices Market Outlook, By Respiratory Devices (2023-2034) ($MN)
  • Table 10 Global Medical Devices Market Outlook, By Diabetes Care Devices (2023-2034) ($MN)
  • Table 11 Global Medical Devices Market Outlook, By Surgical Devices (2023-2034) ($MN)
  • Table 12 Global Medical Devices Market Outlook, By Minimally Invasive Surgical Devices (2023-2034) ($MN)
  • Table 13 Global Medical Devices Market Outlook, By General Surgical Instruments (2023-2034) ($MN)
  • Table 14 Global Medical Devices Market Outlook, By Patient Monitoring Devices (2023-2034) ($MN)
  • Table 15 Global Medical Devices Market Outlook, By Drug Delivery Devices (2023-2034) ($MN)
  • Table 16 Global Medical Devices Market Outlook, By Life Support Equipment (2023-2034) ($MN)
  • Table 17 Global Medical Devices Market Outlook, By Assistive and Rehabilitation Devices (2023-2034) ($MN)
  • Table 18 Global Medical Devices Market Outlook, By Device Class (2023-2034) ($MN)
  • Table 19 Global Medical Devices Market Outlook, By Class I (2023-2034) ($MN)
  • Table 20 Global Medical Devices Market Outlook, By Class II (2023-2034) ($MN)
  • Table 21 Global Medical Devices Market Outlook, By Class III (2023-2034) ($MN)
  • Table 22 Global Medical Devices Market Outlook, By Application (2023-2034) ($MN)
  • Table 23 Global Medical Devices Market Outlook, By Cardiology (2023-2034) ($MN)
  • Table 24 Global Medical Devices Market Outlook, By Orthopedics (2023-2034) ($MN)
  • Table 25 Global Medical Devices Market Outlook, By Neurology (2023-2034) ($MN)
  • Table 26 Global Medical Devices Market Outlook, By Oncology (2023-2034) ($MN)
  • Table 27 Global Medical Devices Market Outlook, By Respiratory Care (2023-2034) ($MN)
  • Table 28 Global Medical Devices Market Outlook, By Diabetes Care (2023-2034) ($MN)
  • Table 29 Global Medical Devices Market Outlook, By Ophthalmology (2023-2034) ($MN)
  • Table 30 Global Medical Devices Market Outlook, By Gynecology and Urology (2023-2034) ($MN)
  • Table 31 Global Medical Devices Market Outlook, By General Surgery (2023-2034) ($MN)
  • Table 32 Global Medical Devices Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 33 Global Medical Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 34 Global Medical Devices Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 35 Global Medical Devices Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 36 Global Medical Devices Market Outlook, By Clinics (2023-2034) ($MN)
  • Table 37 Global Medical Devices Market Outlook, By Diagnostic Laboratories (2023-2034) ($MN)
  • Table 38 Global Medical Devices Market Outlook, By Homecare Settings (2023-2034) ($MN)
  • Table 39 Global Medical Devices Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 40 Global Medical Devices Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 41 Global Medical Devices Market Outlook, By Direct Sales (2023-2034) ($MN)
  • Table 42 Global Medical Devices Market Outlook, By Distributors (2023-2034) ($MN)
  • Table 43 Global Medical Devices Market Outlook, By Online Channels (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.